📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab. (2019)

First Author: Cook LBM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2019.219253

PubMed Identifier: 31004017

Publication URI: http://europepmc.org/abstract/MED/31004017

Type: Journal Article/Review

Volume: 104

Parent Publication: Haematologica

Issue: 12

ISSN: 0390-6078